第一单位：
Department of Internal Medicine V, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
作者：
Maria-Luisa,Schubert [1]
;
Anita,Schmitt [1]
;
Angela,Hückelhoven-Krauss [1]
;
Brigitte,Neuber [1]
;
Alexander,Kunz [1]
;
Philip,Waldhoff [1]
;
Dominik,Vonficht [2]
;
Schayan,Yousefian [3]
;
Lea,Jopp-Saile [2]
;
Lei,Wang [1]
;
Felix,Korell [1]
;
Anna,Keib [1]
;
Birgit,Michels [1]
;
Dominik,Haas [1]
;
Tim,Sauer [1]
;
Patrick,Derigs [1]
;
Andreas,Kulozik [4]
;
Joachim,Kunz [4]
;
Petra,Pavel [5]
;
Sascha,Laier [5]
;
Patrick,Wuchter [6]
;
Johann,Schmier [7]
;
Gesine,Bug [8]
;
Fabian,Lang [8]
;
Nicola,Gökbuget [8]
;
Jochen,Casper [9]
;
Martin,Görner [10]
;
Jürgen,Finke [11]
;
Andreas,Neubauer [12]
;
Mark,Ringhoffer [13]
;
Denise,Wolleschak [14]
;
Monika,Brüggemann [15]
;
Simon,Haas [16]
;
Anthony D,Ho [17]
;
Carsten,Müller-Tidow [17]
;
Peter,Dreger [17]
;
Michael,Schmitt [18]
作者单位：
Department of Internal Medicine V, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
[1]
Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.;Division of Stem Cells and Cancer, Deutsches Krebsforschungszentrum (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.;Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
[2]
Berlin Institute of Health (BIH) at Charité - Universitätsmedizin Berlin, Berlin, Germany.;Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.;Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine, Berlin, Germany.
[3]
Department of Pediatric Hematology, Oncology and Immunology, University Hospital Heidelberg, Heidelberg, Germany.
[4]
Institute for Clinical Transfusion Medicine and Cell Therapy (IKTZ), German Red Cross Blood Service Baden-Württemberg-Hessen, Heidelberg, Germany.
[5]
Institute of Transfusion Medicine and Immunology, Medical Faculty Mannheim, of the Heidelberg University, German Red Cross Blood Service Baden-Württemberg - Hessen, Mannheim, Germany.
[6]
GRN MVZ Sinsheim, Sinsheim, Germany.
[7]
Department of Internal Medicine II, University Hospital Frankfurt, Frankfurt, Germany.
[8]
Department of Hematology and Oncology, University Hospital Oldenburg, Oldenburg, Germany.
[9]
Department of Hematology and Oncology, Hospital Bielefeld, Bielefeld, Germany.
[10]
Department of Internal Medicine I, University Hospital Freiburg, Freiburg, Germany.
[11]
Department of Hematology, Oncology and Immunology, University Hospital Giessen und Marburg, Marburg, Germany.
[12]
Städtisches Klinikum Karlsruhe, Karlsruhe, Germany.
[13]
Department of Hematology and Oncology, Center of Internal Medicine, Otto-von-Guericke University Medical Center, Magdeburg, Germany.
[14]
Department of Internal Medicine II, University Hospital Kiel, Kiel, Germany.
[15]
Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.;Division of Stem Cells and Cancer, Deutsches Krebsforschungszentrum (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.;Berlin Institute of Health (BIH) at Charité - Universitätsmedizin Berlin, Berlin, Germany.;Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.;Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine, Berlin, Germany.;German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ)/National Center for Tumor Diseases (NCT), Heidelberg, Germany.
[16]
Department of Internal Medicine V, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.;German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ)/National Center for Tumor Diseases (NCT), Heidelberg, Germany.
[17]
Department of Internal Medicine V, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany. michael.schmitt@med.uni-heidelberg.de.;German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ)/National Center for Tumor Diseases (NCT), Heidelberg, Germany. michael.schmitt@med.uni-heidelberg.de.
[18]
DOI
10.1186/s13045-023-01470-0
PMID
37481608
发布时间
2023-07-25
换一批
